The Pathologic Characteristics at The Primary Resected Tumor For Pancreatic Neuroendocrine Tumors (PanNETs) That Proved to Have Metastatic Behavior

被引：0

作者：

Bozkurt, Emre ^{[1
]}

Esmer, Rohat ^{[2
]}

Saka, Burcu ^{[2
]}

Eren, Ozgur ^{[3
]}

Bagci, Pelin ^{[3
]}

Balci, Serdar ^{[4
]}

Armutlu, Ayse ^{[5
]}

Sokmensuer, Cenk ^{[6
]}

Xue, Yue ^{[7
]}

Pehlivanoglu, Burcin ^{[8
]}

Reid, Michelle ^{[9
]}

Maithel, Shishir ^{[10
]}

Kooby, David ^{[10
]}

Sarmiento, Juan ^{[11
]}

Taskin, Orhun ^{[5
]}

Kapran, Yersu ^{[5
]}

Gurses, Bengi ^{[1
]}

Tellioglu, Gurkan ^{[1
]}

Bilge, Orhan ^{[12
]}

Basturk, Olca ^{[13
]}

Adsay, N. Volkan ^{[1
]}

机构：

[1] Koc Univ Hosp, Istanbul, Turkiye

[2] Koc Univ, Sch Med, Istanbul, Turkiye

[3] Marmara Univ, Istanbul, Turkiye

[4] Mem Hosp Grp, Pathol Dept, Istanbul, Turkiye

[5] Koc Univ, Istanbul, Turkiye

[6] Hacettepe Univ, Tip Fak, Ankara, Turkiye

[7] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA

[8] Dokuz Eylul Univ, Izmir, Turkiye

[9] Emory Univ Hosp, Atlanta, GA USA

[10] Emory Univ, Atlanta, GA USA

[11] Emory Univ, Atlanta, GA USA

[12] Amer Hosp, Istanbul, Turkiye

[13] Mem Sloan Kettering Canc Ctr, New York, NY USA

来源：

LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1461

引用

页码：S1493 / S1494

页数：2

共 50 条

[31] CONCORDANCE OF PATHOLOGIC FEATURES BETWEEN METASTATIC SITES AND THE PRIMARY TUMOR IN SURGICALLY RESECTED METASTATIC RENAL CELL CARCINOMA
Psutka, Sarah
Cheville, John
Costello, Brian
Lohse, Christine
Stewart, Suzanne
Leibovich, Bradley
Tollefson, Matthew
Thompson, R. Houston
JOURNAL OF UROLOGY, 2014, 191 (04): : E285 - E285
[32] Metastatic pancreatic neuroendocrine tumors have decreased somatostatin expression and increased Akt signaling
Tran, Catherine G.
Scott, Aaron T.
Li, Guiying
Sherman, Scott K.
Ear, Po Hien
Howe, James R.
SURGERY, 2021, 169 (01) : 155 - 161
[33] Metastatic Pancreatic Neuroendocrine Tumors Have Decreased Somatostatin Expression and Increased Akt Signaling
Tran, C.
Scott, A.
Li, G.
Sherman, S.
Ear, P. H.
Howe, J.
PANCREAS, 2021, 50 (03) : 441 - 441
[34] Risk of metastatic spread in patients with early-stage, surgically resected pancreatic neuroendocrine tumors.
Strosberg, J. R.
Cheema, A.
Weber, J.
Kvols, L. K.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
[35] Tumor-Infiltrating Lymphocytes Do Not Affect Ki-67 Labeling Index in a Series of Pancreatic Neuroendocrine Tumors (PanNETs)
Wentz, S. C.
Shi, C.
McCall, C. M.
Sharma, R.
Hruban, R. H.
MODERN PATHOLOGY, 2013, 26 : 432A - 433A
[36] Tumor-Infiltrating Lymphocytes Do Not Affect Ki-67 Labeling Index in a Series of Pancreatic Neuroendocrine Tumors (PanNETs)
Wentz, S. C.
Shi, C.
McCall, C. M.
Sharma, R.
Hruban, R. H.
LABORATORY INVESTIGATION, 2013, 93 : 432A - 433A
[37] Surgical resection of primary tumor is prolonged survival in metastatic pancreatic neuroendocrine carcinoma
Feng, T.
ANNALS OF ONCOLOGY, 2018, 29 : 473 - 473
[38] Resection of primary tumor in liver only metastatic midgut neuroendocrine tumors.
Manguso, Nicholas
Lee, Jaewon
Hendifar, Andrew Eugene
Tuli, Richard
Gangi, Alexandra
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
[39] Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors
Tierney, John F.
Chivukula, Sitaram V.
Wang, Xuanji
Pappas, Sam G.
Schadde, Erik
Hertl, Martin
Poirier, Jennifer
Keutgen, Xavier M.
SURGERY, 2019, 165 (03) : 644 - 651
[40] The Role of Primary Tumor Resection in Patients With Pancreatic Neuroendocrine Tumors With Liver Metastases
Mou, Yu
Wang, Zi-Yao
Tan, Chun-Lu
Chen, Yong-Hua
Liu, Xu-Bao
Ke, Neng-Wen
FRONTIERS IN ONCOLOGY, 2022, 12

← 1 2 3 4 5 →